In today’s highly regulated and competitive business environment, organizations across pharmaceuticals, biotechnology, manufacturing, and allied industries continue to face challenges related to repeat deviations, ineffective CAPA closures, audit observations, and quality failures. CAPA is no longer just a regulatory requirement; it has become a critical driver of operational excellence, brand protection, and customer trust. CAPA X: Quality Without Errors is a focused industry forum designed to transform the way organizations approach Corrective and Preventive Action, shifting the mindset from compliance-driven documentation to meaningful, measurable, and preventive quality improvement.